[Role of Gut Mycobiome in Lung Cancer Immunotherapy: Mechanisms, Challenges and Translational Prospects]. [PDF]
Wang X +5 more
europepmc +1 more source
[Neuroregulatory Mechanisms of Lung Cancer Progression and Clinical Treatment Challenges from the Perspective of Cancer Neuroscience]. [PDF]
Wang N +7 more
europepmc +1 more source
[Clinicopathological, Genomic Characteristics and Prognostic Analysis in 18 Cases of SMARCA4-deficient or SMARCA4-mutated Pulmonary Tumors]. [PDF]
Liu C +6 more
europepmc +1 more source
[Anemoside B4 inhibits non-small cell lung cancer metastasis by modulating epithelial-mesenchymal transition mediated by the MAPK and Keap1/Nrf2 signaling pathways]. [PDF]
Su Q +7 more
europepmc +1 more source
[<i>Shengmai San</i> improves osimertinib resistance of non-small cell lung cancer cells by regulating the lactate/Wnt/β-catenin/LDHA pathway]. [PDF]
Liang Z +6 more
europepmc +1 more source
[The Clinical Application and Development of Tumor Biomarkers in China]. [PDF]
Wang C.
europepmc +1 more source
[Ultrasound-synergized targeted nanoparticles suppress proliferation, migration and invasion of hypoxic lung cancer cells <i>in vitro</i>]. [PDF]
Dong J, Guo J, Li D, DU Y.
europepmc +1 more source
[Liquid Biopsy Revolutionizes the Precise Management of Tumors Across the Entire Course: Current Situation and Future Prospects]. [PDF]
Zeng J, Zhang J.
europepmc +1 more source
[Research Advances in ctDNA-MRD Monitoring in Local Treatment for Non-small Cell Lung Cancer]. [PDF]
Li Z, Wang Y, Wu Y, Guo Z.
europepmc +1 more source
[Ziyuglycoside II Inhibit the Progression of Non-small Cell Lung Cancer through the ITGB4/FAK Signaling Pathway]. [PDF]
Ren J +6 more
europepmc +1 more source

